Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD)

Also known as: Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders / Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12530Inebilizumab2 / 3Completed1